Nocturnal home hemodialysis and its impact on erythropoietin responsiveness.
Anemia secondary to end-stage renal disease (ESRD) is an important but complex syndrome which directly contributes to significant morbidity and mortality in this patient population. The interactions between uremia, bone marrow biology and erythropoietin (EPO) responsiveness are of significant interest to improve our basic understanding of anemia management in ESRD. Nocturnal home hemodialysis is an intensive mode of renal replacement therapy, which has been associated with an improvement in EPO responsiveness. The aims of the present review are (1) to update the recent advances in uremia associated perturbations in bone marrow-derived hematopoietic stem cells and (2) to discuss the potential mechanistic explanations by which augmented uremia clearance may directly affect EPO responsiveness.
Rioux
J-P
JP
Division of Nephrology, Department of Medicine, University Health Network, Toronto, Ontario, Canada.
Chan
C T
CT
D000740:Anemia / Q000209:etiology / Q000517:prevention & control*; D016207:Cytokines / Q000097:blood; D004921:Erythropoietin / Q000494:pharmacology*; D006437:Hemodialysis, Home / Q000379:methods*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000628:therapy*
D016207:Cytokines; D004921:Erythropoietin